Ensysce Biosciences, Inc. (ENSC) vs KALA BIO, Inc. (KALA)
A side-by-side comparison of Ensysce Biosciences, Inc. and KALA BIO, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENSC
Ensysce Biosciences, Inc.
$0.44HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
KALA
KALA BIO, Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 3:21 PM EDT
Total return — ENSC vs KALA
growth of $100 · dividends reinvested · last 9yENSC -100.0% (-71.6%/yr)KALA -100.0% (-72.6%/yr)ENSC compounded faster over this window
ENSC KALA
ENSC vs KALA: by the numbers
- •KALA is the larger company ($7M vs $7M market cap).
- •Both run net losses; KALA's is the smaller (0.00% vs -1084.23% net margin).
Metrics side by side
Valuation
| Metric | ENSC | KALA |
|---|---|---|
| P/S ratio | 5.77 | N/A |
| P/B ratio | N/A | 0.77 |
Profitability
| Metric | ENSC | KALA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -1084.23% | 0.00% |
| ROE | N/A | -111.46% |
| ROIC | N/A | -232.05% |
Growth (annualized)
| Metric | ENSC | KALA |
|---|---|---|
| Total return CAGR (5Y) | -86.22% | -85.73% |
Frequently asked
- How have ENSC and KALA total returns compared?
- Over the past 5 years, ENSC delivered -86.22% and KALA delivered -85.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.